Verastem, Inc. (VSTM) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Verastem, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.294 Good afternoon and welcome to Veristem Oncology's second quarter 2026 earnings conference 00:00:05.294 -- 00:00:09.616 call. My name is Livia and I'll be your call operator today. 00:00:09.616 -- 00:00:14.718 Please note this event is being recorded. All participants will be in a listen-only 00:00:14.718 -- 00:00:20.181 mode. After today's presentation, there will be an opportunity to ask questions. 00:00:20.181 -- 00:00:26.144 I will now turn the call over to Julissa Viana, Senior Vice President, Corporate Communications, 00:00:26.144 -- 00:00:31.206 Investor Relations, and Patient Advocacy at Veristem Oncology. 00:00:32.547 -- 00:00:37.851 Thank you, Operator. Welcome, everyone, and thank you for joining us today to discuss 00:00:37.851 -- 00:00:42.854 Verisem's second quarter 2026 financial results and recent business updates. 00:00:42.854 -- 00:00:46.577 This afternoon, we issued a press release detailing these results, along with a slide 00:00:46.577 -- 00:00:49.659 presentation that we will reference during our call today. 00:00:49.659 -- 00:00:53.382 Both are available on the investor relations section of our website. 00:00:53.382 -- 00:00:57.105 Before we begin, let me point out that we'll be making forward-looking statements that 00:00:57.105 -- 00:00:59.603 are based on our current expectations and beliefs. 00:00:59.603 -- 00:01:03.604 These statements are subject to certain risks and uncertainties, and actual results may 00:01:03.604 -- 00:01:07.705 differ materially. We encourage you to consult the risk factors discussed in our SEC 00:01:07.705 -- 00:01:12.486 filings for additional detail. Additionally, today we'll be discussing certain non-GAAP 00:01:12.486 -- 00:01:16.127 financial measures. Reconciliations to the mo...